CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL. Strullu M, Caye-Eude A, Robert E, Renard JM, et al. Leukemia 2025;39:64-74.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Strullu M, Caye-Eude A, Robert E, Renard JM, et al. CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL. Leukemia 2025;39:64-74.
PMID: 39420220